Gilead Sciences, Inc. (NASDAQ:GILD)

CAPS Rating: 4 out of 5

A biopharmaceutical company that discovers, develops and commercializes innovative therapeutics in areas of unmet medical need.

Recs

0
Player Avatar MAURY56 (< 20) Submitted: 12/31/2010 5:03:15 PM : Outperform Start Price: $36.64 GILD Score: +33.55

HIV is a growth area.

Report this Post Reply

Featured Broker Partners


Advertisement